Days after Sacha Baron Cohen confirmed the end of “Borat”, it seems the British comedian has found lucrative work elsewhere: selling COVID-19 vaccines to celebrities.
In a sketch of Thursday night’s episode of “Jimmy Kimmel Live !,” Cohen was interrupted by what appeared to be a cell phone while answering the question, “Was it fun to play Borat?”
Concluding his serious statement on Borat’s political impact, Cohen apologizes for answering his phone, with a number he seems to recognize. He greets the caller, named Bono.
“Yes, I have AstraZeneca; I have some Pfizer. What do you want? “He asks the caller as he tracks down a mini-fridge in the background, full of oat milk and what appear to be hermetically sealed shots.” Yes, Venmo is fine, “the call concludes.
“Did I hear you right? Was it Bono? Kimmel asks, to which Cohen clarifies, “A different Bonus: Chaz.”
Below are the calls for “Tom Cruise,” initially confused with Tom Hanks and Tom Holland, Kanye West and Wesley Snipes.
“I don’t want to leverage, but are you selling vaccines?” The night host asks.
“Stay out of it, Kimmel,” Cohen replies. “Take care of this beautiful face of yours. There is no vaccine against broken legs.
Later, actor Isla Fisher, Cohen’s wife, enters the picture with a particularly bewildered, stretched-out look, you might say, with a bit of cash. “Dear, dear, Ruffalo is out. Here’s the cash, ”he says, and then asks for“ two Pfizers, one Modern and one Oatly ”for“ Mark Ruffalo ”.
Realizing his careless behavior, Cohen asks Fisher, “Have you been drinking any vaccines?”
After some pressure, he confesses with a strong sigh: “I’ve had 15”.
Kimmel later suggested that the acclaimed satirist should be more focused on Academy Awards than the imposing vaccines.
“That is my Oscar campaign, “Cohen barks.” Jimmy, [I’ll] saying: None of the Hollywood foreign press will receive COVID-19 any time soon. “
True to the roots of Cohen’s satire, the bit actually touches on a real issue amid the deployment of the coronavirus vaccine: the elitism of the vaccine. As several pharmaceutical brands continue to release their version of the antidote COVID-19, a certain insufficiency has arisen that is dangerously undermining the effort to vaccinate all Americans.
In January, a drawing of the British comic Josh Berry he cunningly captures the troubling mentality of framing vaccines as if he were comparing top-tier universities.
“What vaccine did you get?” Berry begins, talking to another imaginary. “Oh that’s great. Me? Oxford. Yeah, everyone in my family had it, so I thought, ‘Why not me?’ You know? I just didn’t want to settle for Pfizer: no offense.”
But doctors warn that constant vaccination of each vaccine, where it was developed, who funded it, or which demographic groups will benefit the most, may risk spreading misinformation.
The effectiveness of cross-brand vaccines has fallen in a spectrum with success rates ranging from 72% (Johnson & Johnson) to about 95% (Pfizer and Moderna), according to studies, which can largely depend on of the age and health status of patients and number of other factors. Despite the scope, doctors have stressed that any vaccine is considerably better than none.
NYU Langone Health epidemiologist Dr. Jennifer L. Lighter suggested the brand “doesn’t matter” in an interview with the university’s news site, published Thursday.
“Get it as soon as you are eligible,” he urged. “Vaccines have been shown to prevent serious diseases and that is our goal.”
Lighter explained that the goal of a vaccine is not necessarily to prevent people from getting sick, but to strengthen their immunity enough to keep them out of the hospital. “If someone has a mild infection, even after vaccination, that’s not a concern,” he said. “What we need is for people to stay out of the hospital and reduce the risk of death.”
He also reiterated that “none of the participants in the trial succeeded [a] the vaccine died due to COVID-19 “.
“There is no clinically significant difference between these vaccines,” Dr. Lighter said. “None. So please don’t hesitate to get vaccinated. “